Detailed answers about JANE MCCLANE PHARMACEUTICALS LTD, including incorporation, status, business activity, and accounts information.
When was JANE MCCLANE PHARMACEUTICALS LTD founded?
JANE MCCLANE PHARMACEUTICALS LTD was officially incorporated on 22 July 2025 and is registered under company number 16599154. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is JANE MCCLANE PHARMACEUTICALS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of JANE MCCLANE PHARMACEUTICALS LTD?
JANE MCCLANE PHARMACEUTICALS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does JANE MCCLANE PHARMACEUTICALS LTD do?
JANE MCCLANE PHARMACEUTICALS LTD operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 21200 - Manufacture of pharmaceutical preparations, 46460 - Wholesale of pharmaceutical goods, 72110 - Research and experimental development on biotechnology. These SIC codes provide insight into the company's business activities and industry focus.
What is JANE MCCLANE PHARMACEUTICALS LTD's registered address?
The registered office address of JANE MCCLANE PHARMACEUTICALS LTD is 21 HOLLYDENE CRESCENT, NOTTINGHAM, ENGLAND, NG6 8QX. This is the official address filed with Companies House for legal and statutory correspondence.
Is JANE MCCLANE PHARMACEUTICALS LTD financially stable?
Financial accounts for JANE MCCLANE PHARMACEUTICALS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.